Assessment of the Global and Regional Impact of Kidney Cancer from 1990 to 2021: Insights and Future Projections from the Global Burden of Disease Study - Scorecard - MDSpire
Advertisement
Assessment of the Global and Regional Impact of Kidney Cancer from 1990 to 2021: Insights and Future Projections from the Global Burden of Disease Study
Clinical Scorecard: Assessment of the Global and Regional Impact of Kidney Cancer from 1990 to 2021: Insights and Future Projections from the Global Burden of Disease Study
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Adults, particularly males, with higher incidence rates and significant challenges in Asian countries.
Care Setting
Key Highlights
five_year_survival_rate
Guideline-Based Recommendations
Diagnosis
Early-stage kidney cancer often lacks typical symptoms; advanced imaging techniques and urine tests are recommended for diagnosis.
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Combination therapies, such as Cabometyx with Opdivo, have shown remarkable efficacy in improving survival rates for advanced kidney cancer.
Clinical Best Practices
Encourage early screening and diagnosis to improve survival rates, supported by recent studies.
Implement lifestyle modification programs to reduce risk factors such as obesity and smoking, based on clinical evidence.
Utilize socioeconomic data to tailor healthcare interventions and resource allocation, referencing relevant studies.
